Schonfeld Strategic Advisors LLC Surmodics Inc Transaction History
Schonfeld Strategic Advisors LLC
- $15.2 Billion
- Q3 2025
A detailed history of Schonfeld Strategic Advisors LLC transactions in Surmodics Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 99,984 shares of SRDX stock, worth $4.16 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
99,984
Previous 148,768
32.79%
Holding current value
$4.16 Million
Previous $4.42 Million
32.38%
% of portfolio
0.02%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding SRDX
# of Institutions
156Shares Held
11.8MCall Options Held
219KPut Options Held
255K-
Black Rock Inc. New York, NY1.17MShares$48.7 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY887KShares$36.9 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA810KShares$33.7 Million0.0% of portfolio
-
Oddo Bhf Asset Management Sas Paris, I0610KShares$25.4 Million0.69% of portfolio
-
Hudson Bay Capital Management LP Greenwich, CT536KShares$22.3 Million0.06% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $583M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...